Concepedia

Milin Acharya

MA

19

Publications

1.4K

Citations

16

H-Index

2004

Active since

Affiliations

Janssen (United States)(Current)

Janssen (Belgium)

National Cancer Institute

Virginia Commonwealth University

Center for Cancer Research

Milin Acharya is an author at Janssen (United States) specializing in medicine, pharmacology, and oncology.

Top concepts

Publications per year

2004–2022

19

Publications

19

Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or Lymphoma

Qin Ryan, Donna Headlee, Milin Acharya et al. · Journal of Clinical Oncology · 2005 · 406 citations · Full text

Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel

Nicola F. Smith, Milin Acharya, Neil Desai et al. · Cancer Biology & Therapy · 2005 · 236 citations · Full text

Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma

Philippe Moreau, Valérie Coiteux, Cyrille Hulin et al. · Haematologica · 2008 · 118 citations · Full text

, , +13

Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma

Donna Reece, Dan M. Sullivan, Sagar Lonial et al. · Cancer Chemotherapy and Pharmacology · 2010 · 106 citations · Full text

, , +6

Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration‐resistant prostate cancer

Kim N., Jennifer L. Spratlin, Christian Kollmannsberger et al. · The Journal of Clinical Pharmacology · 2015 · 101 citations

Rows per page

1–5 of 19